RxDoctor Payments Data

Sabrina Sanchez

Physician Assistant · San Antonio, TXNPI 1881348449

Payments from drug & device makers

$7,338in general payments, 2019–2025

Across 373 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$709
  • Amgen$521
  • GSK$461
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$7,338100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,338 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide23$25,506
OzempicSemaglutide19$24,981
EliquisApixaban21$21,697
FarxigaDapagliflozin Propanediol12$12,904
Albuterol Sulfate HfaAlbuterol Sulfate80$1,474
Fluticasone Propionate72$1,193
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst87$934
Gabapentin80$719
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav75$656
Azelastine Hcl18$563
Doxycycline Monohydrate43$514
Montelukast Sodium39$480
Rosuvastatin Calcium48$478
Famotidine40$464
Losartan Potassium56$455

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$709$25,50623 claims
Novo NordiskOzempic$1,077$24,98119 claims
PfizerEliquis$249$21,69721 claims
AstraZenecaFarxiga$1,034$12,90412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →